The combination of intelligent hardware and APP software to create a closed loop of diabetes management is essential
The two chronic diseases of diabetes and high blood pressure have always been the focus of attention in the medical industry , especially diabetes, for two reasons. First, there are many people with diabetes. On April 6 this year, the World Health Organization released the Global Diabetes Report for the first time. According to the report, in 2014, there were 422 million people with diabetes in the world over 18 years old, which tripled from 108 million patients in 1980 to 2014, accounting for 8.5% of the global population. According to the statistics of the National Health and Family Planning Commission, the proportion of people with diabetes in China is slightly higher than the global average, accounting for 9.7% of the total population. Therefore, the number of diabetic patients in China has exceeded 100 million. Second, the cost of blood glucose testing equipment, medicines, etc. for diabetic patients is huge. Diabetes patients need to continue self-monitoring of blood sugar, consume 6 to 7 pieces of blood glucose paper every day, and the monthly expenses of medicines, insulin, etc., these huge expenses seriously affect social and economic development. The WHO report shows that the annual global cost of responding to diabetes exceeds $827 billion. By 2030, the global economy is expected to lose as much as $1.7 trillion due to diabetes. According to the International Diabetes Federation (IDF) report, direct medical expenses caused by diabetes in China accounted for 13% of the country's total medical expenditure, and it has reached 173.4 billion yuan. The two reasons mentioned above are to discuss why diabetes is the focus of medical enterprises from the perspective of market capacity. The high incidence and high cost have created huge market space. At the same time, diabetes itself has the characteristics of irreversible disease and late complications, which brings huge market demand potential to the diabetes market and forms a relatively long industrial chain of segmentation. In particular, the market space for out-of-hospital treatment and out-of-hospital disease management has prompted entrepreneurs to launch diabetes-related projects. We counted 28 diabetes-related start-ups and conducted an inventory based on project name, start-up time, geographic location, and financing history. The data is available until November 2016. I. Statistics of diabetes-related enterprises Internet + medical start-ups cut into the diabetes market, usually in two ways. One is through the diabetes community, diabetes management APP and other software cut-in, assisting patients in the hospital's out-of-hospital self-management, recording blood sugar changes, assessing the condition, and transmitting diabetes knowledge. The other is through the hardware of the intelligent blood glucose meter, through software-assisted blood glucose recording, the doctor in the background according to the patient's condition to develop an individualized treatment plan, to guide the amount of medication. In the following industry analysis, we will discuss these companies in different categories. 1 Diabetes related enterprise development timetable Most of the diabetes-related companies in our statistics were born after 2011. At that time, the concept of mobile medical treatment was just emerging, and some APP software and online communities began to appear in the community operations for self-management and disease-related knowledge of diabetes patients. In the early days, there were quite a few software apps related to diabetes, more than one hundred models, and the function was based on blood glucose data records. Secondly, there were diabetes knowledge popularization and statistical analysis functions. In the following two years, some enterprises gradually emerged through the development and exploration in operation. By upgrading relevant software functions and operating models, these companies began to connect doctors, patients, hospitals, medicines, and insurance to form a closed loop of the industry chain. The company that can take the lead in realizing this closed loop has gradually grown into a unicorn company in the industry. In addition, around 2013, after the rise of the concept of intelligent hardware, some companies have begun to engage in hardware manufacturing through the cooperation with traditional medical device companies or their own research and development, and launched a smart blood glucose meter. This type of enterprise is the first to introduce diabetes management software, with a large user base and then launch matching smart hardware. Another part of the company relies on the R&D capabilities of hardware to directly introduce smart blood glucose meters, and then the APP supporting blood glucose management enters this market. Although these two types of enterprises have different starting points, they all have their own advantages, and finally achieve the same goal. Through intelligent blood glucose meter and blood glucose movement management, it is an important means for diabetes-related enterprises to deeply cultivate the industry, which can effectively improve the patient's sugar control effect, improve the user's use viscosity by optimizing the user experience, increase the sales of blood glucose equipment and consumables, and accumulate Diabetes-related medical big data . Most diabetes companies were born in 2013 and 2014, which is the fastest and best time for mobile medical companies. Five of them were born in 2013, and 11 were born in 2014. In 2016, we have not yet included information on new diabetes-related companies. After the "Hundred Sugar Battle", some companies with single product functions were gradually eliminated, and the company that can improve the ecological closed-loop of the diabetes industry survived and won the favor of investors. Halal Empty Capsule Size 00,Empty Gelatin Halal Capsule,Halal Empty Gelatin Capsule,Halal Gelatin Capsule Empty Ningbo Jiangnan Capsule Co., Ltd. , https://www.jncapsule.com